Future Neurology

Mouse models have limitations for development of medications for autism spectrum disorders, but also show much promise
pp. 1-4(4)
Authors: Deutsch, Stephen I; Urbano, Maria R; Zemlin, Christian

Protein quality control in Alzheimer''s disease: the contentious role of ubiquilin-1
pp. 5-8(4)
Authors: Boehning, Darren; Barral, José M

Bulletin Board
pp. 9-11(3)

A transgenic mouse model of dementia with Lewy bodies suggests a link between α-synuclein expression, presynaptic vesicle pathology and cognitive deficit
pp. 13-17(5)
Author: Schulz-Schaeffer, Walter J

Channelrhodopsins shed light on a new pathway in absence epilepsy
pp. 19-22(4)
Authors: Petrou, Steven; Reid, Christopher A

Cocaine effects are modulated by central CB₂ receptors in mice: new hope in a cannabinoid target for addiction and other CNS disorders
pp. 23-26(4)
Author: Ward, Sara Jane

10th European Meeting on Glial Cells in Health and Disease
pp. 27-28(2)
Authors: Butt, Arthur M; Bay, Virginia

Improving atherosclerosis risk assessment: looking beyond plaque accumulation to imaging of embolization and healing
pp. 29-36(8)
Authors: Degnan, Andrew J; Gillard, Jonathan H

Placebo-controlled trials in relapsing-remitting multiple sclerosis: are they still needed?
pp. 37-44(8)
Authors: Waschbisch, Anne; Derfuss, Tobias

Spreading depolarization, a pathophysiological mechanism of stroke and migraine aura
pp. 45-64(20)
Authors: Oliveira-Ferreira, Ana I; Winkler, Maren KL; Reiffurth, Clemens; Milakara, Denny; Woitzik, Johannes; Dreier, Jens P

Harnessing adult neurogenesis by cracking the epigenetic code
pp. 65-79(15)
Authors: Jiang, Yindi; Hsieh, Jenny

Vanishing white matter: the next 10 years
pp. 81-92(12)
Author: Proud, Christopher G

Genetic modifiers of Huntington''s disease: beyond CAG
pp. 93-109(17)
Authors: Arning, Larissa; Epplen, Jörg T

Acknowledgements
pp. 111-111(1)